August 11, 2020
Tracy Meffen has served as Vice President, Quality & Regulatory Affairs of Genevant Sciences Corporation since July 2019. Previously, she was Head of Quality & Regulatory Affairs from Genevant’s inception in April 2018. Prior to joining Genevant, Tracy served in QA and RA management roles with Arbutus Biopharma, Lungpacer Medical, and at McKesson. She brings over 25 years of experience in drug and medical device development at various organizations including INEX, Eli Lilly and Genzyme. Tracy holds a MS in Regulatory Affairs from Northeastern University and a BSc in Chemistry from the University of Hull as well as RAC credentials for the United States, Europe and Canada.